These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20960860)

  • 1. [KMO1].
    Kamigaki T
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():736-8. PubMed ID: 20960860
    [No Abstract]   [Full Text] [Related]  

  • 2. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1995; 15(6B):2731-7. PubMed ID: 8669855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical markers in the neoplasms of the liver, biliary tract and pancreas].
    Higashino K; Sumikawa K
    Nihon Rinsho; 1982; 40(1):43-50. PubMed ID: 6177881
    [No Abstract]   [Full Text] [Related]  

  • 5. [CA50].
    Kawabe T
    Nihon Rinsho; 1999 Dec; 57 Suppl():462-5. PubMed ID: 10778165
    [No Abstract]   [Full Text] [Related]  

  • 6. [KMO1].
    Kamigaki T; Kuroda Y
    Nihon Rinsho; 1999 Dec; 57 Suppl():517-9. PubMed ID: 10778178
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of tumor marker CA50].
    Wøldike PM; Charib K; Siboni A
    Ugeskr Laeger; 2008 Sep; 170(38):2985; author reply 2986. PubMed ID: 18816889
    [No Abstract]   [Full Text] [Related]  

  • 8. CA 242--a step ahead.
    Shahi SK; Ranga S; Bhullar C
    Indian J Pathol Microbiol; 2002 Apr; 45(2):145-6. PubMed ID: 12696727
    [No Abstract]   [Full Text] [Related]  

  • 9. [KMO1].
    Kamigaki T; Kuroda Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():691-3. PubMed ID: 16149613
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum].
    Ial'chenko NA; Lagutin VD; Lavik NN; Musin II
    Vopr Onkol; 1991; 37(9-10):921-4. PubMed ID: 1726842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of the determination of 5NU together with CA 19-9 in the diagnosis and monitoring of dyskaryokinetic liver diseases].
    Santini D; Marchei GG; Trasatti L; Di Seri M; Reale MG; Frati I
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):291. PubMed ID: 2092138
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of pancreatic oncofetal antigen, pancreatic cancer associated antigen assay as tumor markers].
    Shimano T; Morimoto H; Saito M; Mori T
    Nihon Rinsho; 1990 Feb; 48 Suppl():917-9. PubMed ID: 2192174
    [No Abstract]   [Full Text] [Related]  

  • 13. Carbohydrate antigen 195 (CA 195) in the sera of patients with esophageal, hepatic and biliary tract carcinomas.
    Andicoechea A; Vizoso F; Alexandre E; Rodriguez JC; Quintela I; Allende M; Ruibal A
    Int J Biol Markers; 1998; 13(2):102-4. PubMed ID: 9803359
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pancreatic and biliary tract cancers].
    Sawada T; Yamada N; Hirakawa K
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):865-71. PubMed ID: 11432359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
    Huang C; Bei L; Liu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood CA 19-9 in the diagnosis of carcinoma of the pancreas: a critical approach].
    Angonese C; Basso D; Del Favero G; Fabris C; Tremolada C; Plebani M; Burlina A; Naccarato R
    Ann Ital Med Int; 1987; 2(2):138-42. PubMed ID: 3275279
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical significance of CA 195 assay as a tumor marker].
    Ohkura H; Sakawaki T
    Nihon Rinsho; 1990 Feb; 48 Suppl():982-4. PubMed ID: 2355639
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical significance of TAC-41 assay as a tumor marker].
    Ariyoshi Y; Kuwabara M; Iwakoshi N; Kito K
    Nihon Rinsho; 1990 Feb; 48 Suppl():1060-3. PubMed ID: 2162412
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of KMO1 for the gastrointestinal disease].
    Okumura S; Ohyanagi H; Saitoh Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():1017-21. PubMed ID: 2192103
    [No Abstract]   [Full Text] [Related]  

  • 20. [2-->6 Sialyl Le(a) antigen].
    Miyazaki K; Kannagi R
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():663-8. PubMed ID: 16149606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.